Why the Supplement Industry Hasn't Changed Since the 1970s

Why the Supplement Industry Hasn't Changed Since the 1970s — And What Micronization Is Doing About It

Imagine walking into a manufacturing facility in 1974. The supplement lines are running. Workers are filling capsules with coarse powdered ingredients, stamping lids, boxing product. The formulas were decided by whoever could source the cheapest raw materials. Quality control was loose. Absorption was an afterthought.

Now fast forward to today. The packaging is completely different. The marketing is sophisticated. The claims are bolder. But walk into the back of most supplement facilities, and you will find something that would look familiar to those 1974 workers: the same large-particle powders, the same basic delivery mechanisms, and the same fundamental indifference to whether any of it actually gets into your bloodstream.

The supplement industry has not meaningfully innovated in formulation technology for fifty years. That is not a criticism. It is a documented reality with real consequences for every consumer buying a product expecting results.

This article covers why that stagnation happened, what it is costing you, why most brands have no incentive to fix it, and what a genuine break from the status quo actually looks like.

 

What's In This Article — Plain English Guide

Serious supplement buyers, pet owners who want real results, and anyone tired of spending money on products that do not deliver will find this article useful. Here is what it covers:

    Why the supplement industry has not meaningfully changed its formulation technology in 50 years. See: Section 1

    What poor absorption is actually costing you — and your pets — every time you buy a standard supplement. See: Section 2

    Why most brands have no incentive to fix the absorption problem See: Section 3

    What micronization does in plain terms, with a link to the full science breakdown.  See: Section 4

    What a supplement brand that actually prioritizes absorption looks like in practice. See: Section 5

Short on time? Jump to Section 2 to understand the dollar-impact of poor absorption, or Section 4 for a plain-language explanation of what micronization actually does. 

Section 1 — The Last Time This Industry Really Changed

The modern supplement industry took shape largely in the 1970s and 1980s. That era established the core manufacturing playbook: source raw ingredients in bulk powder form, combine them with fillers and binders, press them into tablets or fill capsules, and sell on the promise of the ingredient label.

The Dietary Supplement Health and Education Act of 1994 formalized the industry's regulatory framework in the United States, but it did not mandate any standard for absorption, bioavailability, or formulation quality. It required that products be safe and accurately labeled. It said nothing about whether your body could actually use what was inside.

That regulatory gap created a market with very little pressure to innovate. A brand could put 500mg of a compound on its label and technically deliver exactly that, even if only a fraction of it ever reached your bloodstream. As long as the ingredient was present, the claim could be made.

Decades of that incentive structure produced an industry where most brands compete on price, label claims, and marketing, not on whether their product actually works at the cellular level. The formulation technology stayed where it was because there was no financial reason to change it.

Section 2 — What That Stagnation Costs You

Bioavailability is the measure of how much of what you take actually reaches your bloodstream and tissues. It is the gap between what the label says and what your body actually gets.

Research published in peer-reviewed journals has consistently demonstrated that particle size is one of the most significant variables in how well a supplement is absorbed. Reducing particle size increases the surface area exposed for dissolution in the gastrointestinal tract, which in turn increases absorption rate and systemic exposure. [1] For poorly soluble compounds, which describes a large proportion of the active ingredients in common supplements, particle size can be the difference between meaningful absorption and expensive waste. [2]

This is not an abstract concern. A review published in Nutrition and Metabolism examined the fundamental challenge of supplement bioavailability and found that there is a significant and often poorly understood gap between the nutrient content of a supplement and its biological relevance, meaning what the body can actually access and use. [3]

In practical terms, this means a meaningful portion of many standard supplements is never absorbed. It passes through the digestive system and is excreted before it has a chance to do anything. You paid for it. You swallowed it. And your body largely ignored it.

For pet owners, the same principle applies. A poorly formulated supplement that your dog or cat cannot absorb is no different from a supplement that was never given. The label does not tell you what your animal is actually getting. Absorption quality does.

Section 3 — Why Most Companies Have Not Fixed It

Micronization, the process of reducing ingredient particles to the micron scale, is not new science. It has been used in pharmaceutical manufacturing for decades, precisely because research demonstrated its impact on absorption. [4] The question is not whether the technology exists. The question is why most supplement brands are not using it.

The answer is straightforward: micronization requires specialized equipment, tighter quality controls, higher manufacturing standards, and significantly more cost. Jet mills, fluid energy mills, and cryogenic milling systems are expensive to operate and maintain. The raw material handling requirements are more complex. The quality assurance processes are more demanding.

For a brand competing on price, that cost structure is a liability, not an advantage. Most brands making the lowest-cost product have no incentive to invest in formulation quality that consumers cannot see, feel, or measure at the point of purchase. The market rewards the label claim. It does not reward what happens after the capsule dissolves.

The result is an industry where the majority of products are manufactured to a cost standard, not an absorption standard. The technology to do better has existed for years. The business model has simply not demanded it.

Section 4 — What Micronization Actually Does

At its core, micronization is particle size reduction. Ingredients are processed down to the micron scale, which dramatically increases the surface-area-to-volume ratio of each particle. That increased surface area allows the ingredient to dissolve faster and more completely in the gastrointestinal environment, which increases the amount that can be absorbed through the gut wall and into the bloodstream.

For a detailed breakdown of the science behind micronization and how Venjenz applies it, visit venjenz.com/pages/micronization. What matters for this article is the outcome: more of what you take actually reaches the tissues it is intended to support.

Section 5 — What a Real Break from the Status Quo Looks Like

Venjenz was built on the premise that formulation quality is not optional. The entire product line is developed around what the body can actually absorb, not what can be listed on a label at the lowest possible cost.

That starts with micronized ingredients processed to the particle size specifications where absorption research shows meaningful results. It extends to sourcing decisions that prioritize ingredient purity and bioactivity over margin. And it shows up in the finished product in a way that most supplement brands simply cannot match, because most supplement brands never made the decision to invest in the manufacturing infrastructure required to do it.

The same standard applies to Venjenz's pet formulations. The animals in your household deserve the same level of formulation integrity as you do. A supplement that does not absorb is not a supplement. It is an expense.

Fifty years of industry inertia does not disappear because a brand changes its packaging. It disappears when the formulation itself changes. That is the only thing that actually matters.

The Bottom Line

The supplement industry has spent five decades perfecting how to market products without any obligation to ensure those products work at the level of absorption and bioavailability. That is not a failure of regulation alone. It is a failure of ambition.

Micronization is one of the clearest available tools for closing the gap between what a supplement label promises and what your body actually receives. The brands that have adopted it have done so because they decided that the gap matters.

Ready to understand the full science? Visit the Micronization educational page for a complete breakdown. And explore the Venjenz product line to see what formulation integrity looks like in practice.

 

Sources and Citations

1.     Sugano, K., et al. "Optimizing Particle Size Distribution for Oral Drug Formulations Using the Refined Developability Classification System." PMC10385664. https://pmc.ncbi.nlm.nih.gov/articles/PMC10385664/

2.     Kawabata, Y., et al. "Formulation Design for Poorly Water-Soluble Drugs Based on Biopharmaceutics Classification System." International Journal of Pharmaceutics, 2011. PMID: 21664270. https://pubmed.ncbi.nlm.nih.gov/21664270/

3.     Pressman, P., Clemens, R.A., Hayes, A.W. "Bioavailability of Micronutrients Obtained from Supplements and Food." Nutrition and Metabolism, 2017. https://doi.org/10.1177/2397847317696366

4.     Boudreaux, J.P., et al. "Micronization: A Method of Improving the Bioavailability of Poorly Soluble Drugs." PubMed PMID: 9646283. https://pubmed.ncbi.nlm.nih.gov/9646283/

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.